Joseph M. Lane, MD
Joseph M. Lane, M.D. was born in New York City and raised in Great Neck, Long Island. He received his AB degree (Magna Cum Laude) from Columbia College (1961) and his M.D. from Harvard Medical School (1965). General surgical internship and residency were performed at the Hospital of the University of Pennsylvania (1965-67). Dr. Lane performed bone collagen research at the NIDR at NIH (USPHS) from 1967-69 in Bethesda, Maryland, under Karl Piez and Edward Miller. He had a collagen research fellowship under Darwin Prochop at the CCRC University of Pennsylvania (1969-70) and a three-year orthopaedic residency at the Hospital of the University of Pennsylvania during which time he was awarded the Kappa Delta Award (AAOS) for inhibiting scar formation.
Dr. Lane was the Elsee Butz Assistant Professor (Orthopaedics) at the Hospital University of Pennsylvania and Children’s Hospital of Philadelphia (1973-75). He was appointed Assistant Professor and Chief of the Metabolic Bone Disease Service at the Hospital for Special Surgery at Cornell Medical School in 1975, ultimately attaining full Professorship, Assistant Dean, Director of Clinical Research, and Medical Director of the Metabolic Bone Disease Service and Osteoporosis Prevention (1976-93, 96—present). He was appointed Chief of the Bone Tumor Service (osteogenic sarcoma, Ewing’s sarcoma) at the Memorial Sloan-Kettering Cancer Center (1976-91) and Senior Attending (1991-93). From 1993-96 he was Professor and Chairman of the Department of Orthopaedic Surgery at UCLA.
AppointmentsAttending Orthopaedic Surgeon, Hospital for Special Surgery
Assistant Dean, Hospital for Special Surgery,Weill Medical College of Cornell University and affiliated hospitals, NYC
Professor of Orthopaedic Surgery, Weill Medical College of Cornell University, New York, New York
Adjunct Professor, Department of Orthopaedic Surgery, Columbia University, College of Physicians & Surgeons, New York
Chief, Metabolic Bone Disease Service
Attending Orthopaedic Surgeon, Hospital for Special Surgery, NewYork Hospital
National Board of Medical Examiners
American Board of Orthopaedic Surgeons, September 1974
Board Recertification—American Board of Orthopaedic Surgeons, July 1998
MD, Harvard Medical School, 1965, US
Hospital of the University of Pennsylvania , Department of General Surgery, Pennsylvania, US, 1966-67
Hospital of the University of Pennsylvania , Department of Orthopaedic Surgery, Pennsylvania, US, 1972-73
National Institute of Arthritis and Metabolic Disease, NIH (USPHS), Research Associate, US
General Clinical Research Center, Collagen Metabolism (Darwin Prochop), Research Associate, US
For Patients
For ProfessionalsSpecial Expertise
- Role of Wnt Signaling in Bone Remodeling and Repair
- Alendronate Inhibits PTH (1-34)-Induced Bone Morphogenetic Protein Expression in MC3T3-E1 Preosteoblastic Cells
- The Modern Approach to the Prevention and Treatment of Spine Fractures
- Osteoporosis
- How Much Calcium is in Your Drinking Water? A Survey of Calcium Concentrations in Bottled and Tap Water and Their Significance for Medical Treatment and Drug Administration
- Intravenous Bisphosphonate Treatment for Osteoporosis
Malignant and benign bone tumors (osteoglenic, Ewing’s, and soft-tissue sarcomas
Fractures, non-unions, and delayed healing
Metabolic bone disease (osteoporosis, Paget’s disease, rickets, osteomalacia, fibrous dysplasia, melorheostosis)
Geriatric vertebral compression fractures
Geriatric hip fractures
FDA Orthopaedic Panel, 1999—current
New York State Osteoporosis and Education Program (NYSOPEP), 1999
NIH Tissue Engineering Grant Review Panel, 1998—current
NIH Sickle Cell Hip Program—Oversight Committee, 1998—current
NIH Consensus on Total Hip Replacement—Panelist, 1994